Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study on Sentinel Node Biopsy Using Two Concurrent Labelling Techniques (Radioactive Tracer With/Without Blue Dye vs. Indocyanine Green-ICG) in Early-stage Endometrial Cancer Patients (TESLA-1).

NCT04665544 is registered in ClinicalTrials.gov with University Medical Centre Maribor as lead sponsor.

NCT NCT04665544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04665544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study on Sentinel Node Biopsy Using Two Concurrent Labelling Techniques (Radioactive Tracer With/Without Blue Dye vs. Indocyanine Green-ICG) in Early-stage Endometrial Cancer Patients (TESLA-1).
Lead sponsor
University Medical Centre Maribor
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2021
Completion date
January 1, 2024
Enrollment
83 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, sentinel lymph node